Stockholders’ Equity (Deficit) (Details) - Schedule of Stock Warrants - $ / shares |
9 Months Ended | 12 Months Ended | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
||||||||||||||
Stockholders’ Equity (Deficit) (Details) - Schedule of Stock Warrants [Line Items] | ||||||||||||||||
Beginning balance, outstanding | 51,465,978 | 5,813,804 | ||||||||||||||
Issued | 59,747,574 | |||||||||||||||
Exercised (in Dollars per share) | $ (14,095,400) | |||||||||||||||
Expired (in Dollars per share) | ||||||||||||||||
Ending balance, outstanding | 51,465,978 | 51,465,978 | ||||||||||||||
2019 Public Warrants [Member] | ||||||||||||||||
Stockholders’ Equity (Deficit) (Details) - Schedule of Stock Warrants [Line Items] | ||||||||||||||||
Exercise Price (in Dollars per share) | $ 230 | [1] | $ 230 | [2] | ||||||||||||
Expiration Date | Jun. 19, 2024 | [1] | Jun. 19, 2024 | [2] | ||||||||||||
Beginning balance, outstanding | [2] | 5,813,804 | [1] | 5,813,804 | ||||||||||||
Issued | [2] | |||||||||||||||
Exercised (in Dollars per share) | [1] | [2] | ||||||||||||||
Expired (in Dollars per share) | [1] | [2] | ||||||||||||||
Ending balance, outstanding | [1] | 5,813,804 | 5,813,804 | [2] | ||||||||||||
Pre-funded Warrants [Member] | ||||||||||||||||
Stockholders’ Equity (Deficit) (Details) - Schedule of Stock Warrants [Line Items] | ||||||||||||||||
Exercise Price (in Dollars per share) | [3] | $ 0.002 | ||||||||||||||
Expiration Date | [3] | Jun. 29, 2027 | ||||||||||||||
Beginning balance, outstanding | [3] | |||||||||||||||
Issued | [3] | 14,095,400 | ||||||||||||||
Exercised (in Dollars per share) | [3] | $ (14,095,400) | ||||||||||||||
Expired (in Dollars per share) | [3] | |||||||||||||||
Ending balance, outstanding | [3] | |||||||||||||||
Common Warrant [Member] | ||||||||||||||||
Stockholders’ Equity (Deficit) (Details) - Schedule of Stock Warrants [Line Items] | ||||||||||||||||
Exercise Price (in Dollars per share) | [4] | $ 4.6 | ||||||||||||||
Expiration Date | [4] | Jun. 29, 2027 | ||||||||||||||
Beginning balance, outstanding | [4] | 43,478,261 | ||||||||||||||
Issued | [4] | 43,478,261 | ||||||||||||||
Exercised (in Dollars per share) | [4] | |||||||||||||||
Expired (in Dollars per share) | [4] | |||||||||||||||
Ending balance, outstanding | [4] | 43,478,261 | ||||||||||||||
Underwriter Warrants [Member] | ||||||||||||||||
Stockholders’ Equity (Deficit) (Details) - Schedule of Stock Warrants [Line Items] | ||||||||||||||||
Exercise Price (in Dollars per share) | $ 0.37 | [5] | $ 4.6 | [4] | ||||||||||||
Expiration Date | Jun. 29, 2027 | [5] | Jun. 29, 2027 | [4] | ||||||||||||
Beginning balance, outstanding | [4] | 2,173,913 | [5] | |||||||||||||
Issued | [4] | 2,173,913 | ||||||||||||||
Exercised (in Dollars per share) | [5] | [4] | ||||||||||||||
Expired (in Dollars per share) | [5] | [4] | ||||||||||||||
Ending balance, outstanding | [5] | 2,173,913 | 2,173,913 | [4] | ||||||||||||
|